Webinar: High-content analysis and phenotypic characterisation of 2D and 3D cellular models
Posted: 20 October 2020 | Molecular Devices | No comments yet
Combining 2D and 3D models with live-cell assays allows monitoring of cell responses in real time and provides important insights about compound treatment effects, biological complexity, and physiological relevance of assay results.
In this webinar, Molecular Devices scientists discuss how to:
• Use high-content analysis to analyse multiple parameters across high-throughput compound screens
• Overcome challenges in automating 3D organoid imaging with robust and flexible autofocusing methods and targeted imaging workflows
• Characterise compound effects on tumor spheroid phenotypes and volumetric changes in 3D cellular content with 3D image analysis algorithms
Related content from this organisation
- The role of CRISPR in microbiome engineering breakthroughs
- Episode 15 – Minimise variability issues in your organoids
- Episode 14 – Complex assays with Ian Shoemaker, Beckman Coulter Life Sciences & Dr Oksana Sirenko, Molecular Devices
- Episode 12 – ELISA assays with Dr Ana Miletic and Anna Dey, Kyowa Kirin & Dr Cathy Olsen, Molecular Devices
- Molecular Devices and HeartBeat.bio announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
Related topics
Analytical Techniques, Assays, Disease Research, Hit-to-Lead, Imaging, Lab Automation, Microscopy, Screening, Targets, Toxicology
Related organisations
Molecular Devices
![In experiments in rats and mice, two Johns Hopkins scientists -- an engineer and an ophthalmologist -- report the successful use of nanoparticles to deliver gene therapy for blinding eye disease. A uniquely engineered large molecule allows researchers to compact large bundles of therapeutic DNA to be delivered into the cells of the eye [credit: John Hopkins Medicine].](https://www.drugtargetreview.com/wp-content/uploads/nanoparticle-gene-therapy-blindness-image-400x187.jpg)